During the early 1990s,
the World Health Organization (WHO) had been overseeing massive
vaccination campaigns against tetanus in a number of countries,
among them Nicaragua, Mexico, and the Philippines. In October
1994, HLI received a communication from its Mexican affiliate,
the Committee' Pro Vida de Mexico, regarding that country's anti-tetanus
campaign. Suspicious of the campaign protocols, the Committee'
obtained several vials of the vaccine and had them analysed by
chemists. Some of the vials were found to contain human chorionic
gonadotrophin (hCG), a naturally occurring hormone essential for
maintaining a pregnancy.
hCG and Anti-hCG Antibodies
In nature the hCG hormone alerts
the woman's body that she is pregnant and causes the release of
other hormones to prepare the uterine lining for the implantation
of the fertilized egg. The rapid rise in hCG levels after conception
makes it an excellent marker for confirmation of pregnancy: when
a woman takes a pregnancy test she is not tested for the pregnancy
itself, but for the elevated presence of hCG.
However, when introduced into the
body coupled with a tetanus toxoid carrier, antibodies will be
formed not only against tetanus but also against hCG. In this
case the body fails to recognize hCG as a friend and will produce
anti-hCG antibodies. The antibodies will attack subsequent pregnancies
by killing the hCG which naturally sustains a pregnancy; when
a woman has sufficient anti-hCG antibodies in her system, she
is rendered incapable of maintaining a pregnancy.(1)
HLI reported the sketchy facts
regarding the Mexican tetanus vaccines to its World Council members
and affiliates in more than 60 countries.(2) Soon additional reports
of vaccines laced with hCG hormones began to drift in from the
Philippines, where more than 3.4 million women were recently vaccinated.
Similar reports came from Nicaragua, which had conducted its own
vaccination campaign in 1993.
The Known Facts
Here are the known facts concerning
the tetanus vaccination campaigns in Mexico and the Philippines:
* Only women are vaccinated, and
only the women between the ages of 15 and 45. (In Nicaragua the
age range was 12-49.) But aren't men at least as likely as young
women to come into contact with tetanus? And what of the children?
Why are they excluded?
* Human chorionic gonadotrophin
(hCG) hormone has been found in the vaccines. It does not belong
there -- in the parlance of the O.J. Simpson murder trial, the
vaccine has been "contaminated."
* The vaccination protocols call
for multiple injections -- three within three months and a total
of five altogether. But, since tetanus vaccinations provide protection
for ten years or more, why are multiple inoculations called for?(3)
* WHO has been actively involved
for more than 20 years in the development of an anti-fertility
vaccine utilizing hCG tied to tetanus toxoid as a carrier -- the
exact same coupling as has been found in the Mexican-Philippine-Nicaragua
vaccines.(4)
The Anti-Fertility Gang
Allied with the WHO in the development
of an anti-fertility vaccine (AFV) using hCG with tetanus and
other carriers have been UNFPA, the UN Development Programme (UNDP),
the World Bank, the Population Council, the Rockefeller Foundation,
the All India Institute of Medical Sciences, and a number of universities,
including Uppsala, Helsinki, and Ohio State.(5) The U.S. National
Institute of Child Health and Human Development (part of NIH)
was the supplier of the hCG hormone in some of the AFV experiments.(6)
The WHO begain its "Special
Programme" in human reproduction in 1972, and by 1993 had
spent more than $356 million on "reproductive health"
research.(7) It is this "Programme" which has pioneered
the development of the abortificant vaccine. Over $90 million
of this Programme's funds were contributed by Sweden; Great Britain
donated more than $52 million, while Norway, Denmark and Germany
kicked in for $41 million , $27 million, and $12 million, respectively.
The U.S., thanks to the cut-off of such funding during the Reagan-Bush
administrations, has contributed "only" $5.7 million,
including a new payment in 1993 by the Clinton administration
of $2.5 million. Other major contibutors to the WHO Programme
include UNFPA, $61 million; the World Bank, $15.5 million; the
Rockefeller Foundation, $2.5 million; the Ford Foundation, over
$1 million; and the IDRC (International Research and Development
Centre of Canada), $716.5 thousand.
WHO and Philippine Health Department
Excuses
When the first reports surfaced
in the Philippines of tetanus toxoid vaccine being laced with
hCG hormones, the WHO and the Philippine Department of Health
(DOH) immediately denied that the vaccine contained hCG. Confronted
with the results of laboratory tests which detected its presence
in three of the four vials of tetanus toxoid examined, the WHO
and DOH scoffed at the evidence coming from "right-to-life
and Catholic" sources. Four new vials of the tetanus vaccine
were submitted by DOH to St. Luke's (Lutheran) Medical Center
in Manila -- and all four vials tested positive for hCG!
From outright denial the stories
now shifted to the allegedly "insignificant" quantity
of the hCG present; the volume of hCG present is insufficient
to produce anti-hCG antibodies.
But new tests designed to detect
the presence of hCG antibodies in the blood sera of women vaccinated
with the tetauns toxoid vaccine were undertaken by Philippine
pro-life and Catholic groups. Of thirty women tested subsequent
to receiving tetanus toxoid vaccine, twenty-six tested positive
for high levels of anti-hCG! If there were no hCG in the vaccine,
or if it were present in only "insignificant" quantities,
why were the vaccinated women found to be harboring anti-hCG antibodies?
The WHO and the DOH had no answers.
New arguments surfaced: hCG's apparent
presence in the vaccine was due to "false positives"
resulting from the particular substances mixed in the vaccine
or in the chemicals testing for hCG. And even if hCG was really
there, its presence derived from the manufacturing process.
But the finding of hCG antibodies
in the blood sera of vaccinated women obviated the need to get
bogged down in such debates. It was no longer necessary to argue
about what may or may not have been the cause of the hCG presence,
when one now had the effect of the hCG. There is no known way
for the vaccinated women to have hCG antibodies in their blood
unless hCG had been artificially introduced into their bodies!
Why A Tetanus Toxoid "Carrier"?
Because the human body does not
attack its own naturally occurring hormone hCG, the body has to
be fooled into treating hCG as an invading enemy in order to develop
a successful anti-fertility vaccine utilizing hCG antibodies.
A paper delivered at the 4th International Congress of Reproductive
Immunology (Kiel, West Germany, 26-29 July 1989) spelled it out:
"Linkage to a carrier was done to overcome the immunological
tolerance to hCG."(8)
Vaccine Untested by Drug Bureau
After the vaccine controversy had
reached a fever pitch, a new bombshell exploded; none of the three
different brands of tetanus vaccine being used had ever been licensed
for sale and distribution or registered with the Philippine Bureau
of Food and Drugs (BFAD), as required by law. The head of the
BFAD lamely explained that the companies distributing these brands
"did not apply for registration."(9) The companies in
question are Connaught Laboratories Ltd. and Intervex, both from
Canada, and CSL Laboratories from Australia.
It seemed that the BFAD might belatedly
require re-testing, but the idea was quickly rejected when the
Secretary of Health declared that, since the vaccines had been
certified by the WHO -- there they are again! -- there was assurance
enough that the "vaccines come from reputable manufacturers."(10)
Just how "reputable"
one of the manufacturers might be is open to some question. In
the mid-`80s Connaught Laboratories was found to be knowingly
distributing vials of AIDS-contaminated blood products.(11)
Epilogue
At this juncture, evidence is beginning
to appear from Africa.(12) HLI has called for a Congressional
investigation of the situation, inasmuch as nearly every agency
involved in the development of an anti-fertility vaccine is funded,
at least in part, with U.S. monies.
NOTES:
(1) "Abortifacient vaccines
loom as new threat," HLI Reports, November 1993, pp. 1-2.
(2) World Council Reports, 28 November
1994, pp. 4-5.
(3) A call placed by this writer
on 5 May 1995 to the Montgomery County (Maryland) Health Department,
Epidemology Division -- Infectious Diseases -- Adult Immunizations,
elicited the following information:
Q. For how long a time
does the tetanus vaccination offer protection?
A. 10 years.
Q. Have you ever heard of any adult requiring three tetanus vaccinations
within a 3 or 4 month time period, and a total of 5 vaccinations
in all within a year or so?
A. Whaaaat! Never. No way!
Reports from the Philippines appear
to confirm the 10-year immunity afforded by tetanus toxoid vaccinations:
prior to the campaigns begun in 1993, the so-called booster shots
were given only every 10 years.
(4) More than a score of articles,
many written by WHO researchers, document WHO's attempts to create
an anti-fertility vaccine utilizing tetanus toxoid as a carrier.
Some leading articles include:
"Clinical profile
and Toxicology Studies on Four Women Immunized with Pr-B-hCG-TT,"
Contraception, February, 1976, pp. 253-268.
"Observations on the antigenicity
and clinical effects of a candidate antipregnancy vaccine: B-subunit
of human chorionic gonadotropin linked to tetanus toxoid,"
Fertility and Sterility, October 1980, pp. 328-335.
"Phase 1 Clinical Trials
of a World Health Organisation Birth Control Vaccine,"
The Lancet, 11 June 1988, pp. 1295-1298. "Vaccines for
Fertility Regulation," Chapter 11, pp. 177-198, Research
in Human Reproduction, Biennial Report (1986-1987), WHO Special
Programme of Research, Development and Research Training in
Human Reproduction (WHO, Geneva 1988).
"Anti-hCG Vaccines are in
Clinical Trials," Scandinavian Journal of Immunology, Vol.
36, 1992, pp. 123-126.
(5) These institutional names are
garnered from the journal articles cited in the previous footnote.
(6) Lancet, 11 June 1988, p. 1296.
(7) Challenges in Reproductive
Health Research, Biennial Report 1992-1993, World Health Organization,
Geneva, 1994, p. 186.
(8) G.P. Talwar, et al, "Prospects
of an anti-hCG vaccine inducing antibodies of high affinity...(etc),"
Reproductive Technology 1989, Elsevier Science Publishers, 1990,
Amsterdam, New York, p. 231.
(9) "3 DOH vaccines untested
by BFAD," The Philippine Star, 4 April 1995, pp. 1, 12.
(10) "BFAD junks re-testing
of controversial shot," Manila Standard, 7 April 1995; "DOH:
Toxoid vaccines are safe," The Philippine Star, 7 April 1995.
(11) "Ottawa got blood tainted
by HIV." Ottawa Citizen, 4 April 1995.
(12) A nearly two-year old communiqué
from Tanzania tells a familiar story: tetanus toxoid vaccinations,
five in all, given only to women aged 15-45. Nigeria, too, may
have been victimized; see The Lancet, 4 June 1988, p. 1273.
Credit: Copyright June/July 1995
by James A. Miller, special correspondent for Human Life International.
This article was originally published in HLI Reports, Human Life
International, Gaithersburg, Maryland; June/July 1995, Volume
13, Number 8. Permission to reprint granted to Think twice/New
Atlantean Press.
